Dallas-based Biotech CerSci Acquired by ACADIA Pharmaceutical in $52.5M Deal

by | Aug 25, 2020
CerSci shareholders could net another $887 million in milestones and tiered royalties. The clinical-stage startup, which launched in 2015, is developing a new generation of non-opioid meds to treat acute and chronic pain.
McKesson and TrakCel Form a Collaboration to Commercialize Cell and Gene Therapies
by | Sep 12, 2019
Together, the two companies aim to increase access to complex medications and ensure that patients more quickly receive the correct drug at the right time.
‘Smart Pills’ Help Monitor Children’s Health Patients
by | Feb 28, 2017
The so-called “smart pill” technology, once ingested, transmits a signal to a patch that patients wear on their torsos.
ReCode Therapeutics
Researcher Tackles Tuberculosis Medication Testing
by | Oct 27, 2016
Tuberculosis is still a major health issue in some parts of the world, and Dr. Gumbo's research could help find better treatments.